• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素通过靶向 MSK1/IRS1 轴上调 miR-148a 增加 CD44 阳性前列腺癌干细胞对紫杉醇的化疗敏感性。

Curcumin Upregulates miR-148a to Increase the Chemosensitivity of CD44-Positive Prostate Cancer Stem Cells to Paclitaxel Through Targeting the MSK1/IRS1 axis.

机构信息

Research Laboratory for Embryology and Stem Cells, Department of Anatomical Sciences, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.

Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.

出版信息

Drug Res (Stuttg). 2022 Oct;72(8):457-465. doi: 10.1055/a-1867-4805. Epub 2022 Jul 22.

DOI:10.1055/a-1867-4805
PMID:35868335
Abstract

BACKGROUND

In men, prostate cancer (PC) is the second most common cause of cancer-related death. However, paclitaxel resistance is a major challenge in advanced PC. Curcumin, a natural antioxidant, has been demonstrated to have cytotoxic effects on cancer stem cells (CSCs). The goal of this study is to explore if curcumin can help lower chemoresistance to paclitaxel through the regulation of miR-148a-mediated apoptosis in prostate CSCs.

METHODS

The 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay and 4',6-diamidino-2-phenylindole (DAPi) labeling were used to determine cell survival. Immunohistochemistry was used to detect the expression of P-glycoprotein protein (P-gp) and CD44 proteins. Finally, real-time PCR was used to evaluate the regulatory effects of curcumin and paclitaxel on miR-148a and its target genes.

RESULTS

Curcumin and paclitaxel co-treatment significantly reduced the IC value in CD44cells compared to paclitaxel alone. Additionally, combining these drugs considerably increased apoptosis in CD44cells. We also discovered that when curcumin and paclitaxel were combined, the expression of CD44 and P-gp was significantly reduced compared to paclitaxel alone. Curcumin and paclitaxel co-treatment also increased miR-148a levels and regulated the levels of its target genes MSK1 and IRS1.

CONCLUSION

Curcumin may restore paclitaxel sensitivity by raising miR-148a expression and inhibiting its target genes.

摘要

背景

在男性中,前列腺癌(PC)是癌症相关死亡的第二大常见原因。然而,紫杉醇耐药是晚期 PC 的主要挑战。姜黄素是一种天然抗氧化剂,已被证明对癌症干细胞(CSC)具有细胞毒性作用。本研究旨在探讨姜黄素是否可以通过调节 miR-148a 介导的前列腺 CSC 细胞凋亡来帮助降低紫杉醇的化疗耐药性。

方法

使用 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)测定法和 4',6-二脒基-2-苯基吲哚(DAPi)标记法来确定细胞存活率。免疫组织化学法用于检测 P-糖蛋白蛋白(P-gp)和 CD44 蛋白的表达。最后,实时 PCR 用于评估姜黄素和紫杉醇对 miR-148a 及其靶基因的调节作用。

结果

与单独使用紫杉醇相比,姜黄素和紫杉醇联合治疗显著降低了 CD44 细胞中的 IC 值。此外,联合使用这些药物可显著增加 CD44 细胞的凋亡。我们还发现,与单独使用紫杉醇相比,姜黄素和紫杉醇联合使用时 CD44 和 P-gp 的表达明显降低。姜黄素和紫杉醇联合治疗还可提高 miR-148a 水平并调节其靶基因 MSK1 和 IRS1 的水平。

结论

姜黄素可能通过提高 miR-148a 的表达并抑制其靶基因来恢复紫杉醇的敏感性。

相似文献

1
Curcumin Upregulates miR-148a to Increase the Chemosensitivity of CD44-Positive Prostate Cancer Stem Cells to Paclitaxel Through Targeting the MSK1/IRS1 axis.姜黄素通过靶向 MSK1/IRS1 轴上调 miR-148a 增加 CD44 阳性前列腺癌干细胞对紫杉醇的化疗敏感性。
Drug Res (Stuttg). 2022 Oct;72(8):457-465. doi: 10.1055/a-1867-4805. Epub 2022 Jul 22.
2
MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression.miR-148a 通过调控 MSK1 表达抑制激素难治性、耐药性前列腺癌 PC3 细胞对紫杉醇的耐药性。
J Biol Chem. 2010 Jun 18;285(25):19076-84. doi: 10.1074/jbc.M109.079525. Epub 2010 Apr 20.
3
MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.微小RNA-34a通过直接抑制JAG1/Notch1轴减轻前列腺癌细胞对紫杉醇的耐药性。
Cell Physiol Biochem. 2018;50(1):261-276. doi: 10.1159/000494004. Epub 2018 Oct 3.
4
Co-Delivery of Curcumin and Paclitaxel by "Core-Shell" Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer.载姜黄素和紫杉醇的“核壳”靶向两亲性共聚物逆转卵巢癌细胞耐药性的治疗作用
Int J Nanomedicine. 2019 Dec 2;14:9453-9467. doi: 10.2147/IJN.S224579. eCollection 2019.
5
Cytotoxicity of curcumin against CD44 prostate cancer cells: Roles of miR-383 and miR-708.姜黄素对CD44前列腺癌细胞的细胞毒性:miR-383和miR-708的作用
Avicenna J Phytomed. 2023 Jul-Aug;13(4):429-441. doi: 10.22038/AJP.2023.21913.
6
Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway.前列腺癌细胞中的化疗耐药性受 miRNAs 和 Hedgehog 通路的调控。
PLoS One. 2012;7(6):e40021. doi: 10.1371/journal.pone.0040021. Epub 2012 Jun 29.
7
Inhibition of aldehyde dehydrogenase-1 and p-glycoprotein-mediated multidrug resistance by curcumin and vitamin D3 increases sensitivity to paclitaxel in breast cancer.姜黄素和维生素 D3 抑制醛脱氢酶-1 和 P-糖蛋白介导的多药耐药性,增加乳腺癌对紫杉醇的敏感性。
Chem Biol Interact. 2020 Jan 5;315:108865. doi: 10.1016/j.cbi.2019.108865. Epub 2019 Oct 16.
8
CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel.CD133 抑制可提高前列腺癌细胞对紫杉醇的敏感性。
Mol Biol Rep. 2020 May;47(5):3691-3703. doi: 10.1007/s11033-020-05411-9. Epub 2020 Apr 3.
9
Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis.桑色素通过miR-155/GATA3轴促进前列腺癌细胞对紫杉醇的化学敏感性。
Oncotarget. 2017 Jul 18;8(29):47849-47860. doi: 10.18632/oncotarget.18133.
10
Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.敲低长链非编码 RNA CCAT1 通过调控 miR-24-3p 和 FSCN1 增强前列腺癌对紫杉醇的敏感性。
Cancer Biol Ther. 2020 May 3;21(5):452-462. doi: 10.1080/15384047.2020.1727700. Epub 2020 Feb 23.

引用本文的文献

1
Hepatocellular carcinoma stem cells: the current state of small molecule-based inhibitors.肝细胞癌干细胞:基于小分子抑制剂的研究现状
Cell Death Dis. 2025 Sep 1;16(1):666. doi: 10.1038/s41419-025-07983-5.
2
Regulation of Apoptosis, Autophagy, and Metastasis by Luteolin in Human Bladder Cancer EJ138 Cells: An Experimental Study.木犀草素对人膀胱癌EJ138细胞凋亡、自噬和转移的调控:一项实验研究
Iran J Pharm Res. 2024 Nov 16;23(1):e153408. doi: 10.5812/ijpr-153408. eCollection 2024 Jan-Dec.
3
Epigenetic and biogenetic regulation by polyphenols in prostate cancer in the context of 3P medicine.
在3P医学背景下,多酚对前列腺癌的表观遗传和生物遗传调控。
EPMA J. 2024 Dec 21;16(1):113-125. doi: 10.1007/s13167-024-00391-3. eCollection 2025 Mar.
4
Metformin reverses 5-FU chemoresistance by downregulating DKK1, WNT5A, and ABCB1 expressions in gastric cancer: An experimental and bioinformatic study.二甲双胍通过下调胃癌中DKK1、WNT5A和ABCB1的表达逆转5-氟尿嘧啶化疗耐药性:一项实验和生物信息学研究
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 15. doi: 10.1007/s00210-025-03879-5.
5
MiRNAs: main players of cancer drug resistance target ABC transporters.微小RNA:癌症耐药性的主要作用靶点是ABC转运蛋白。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 14. doi: 10.1007/s00210-024-03719-y.
6
The Association Between Anti-Neoplastic Effects of Curcumin and Urogenital Cancers: A Systematic Review.姜黄素的抗肿瘤作用与泌尿生殖系统癌症的关系:系统评价。
Biomed Res Int. 2024 Oct 15;2024:9347381. doi: 10.1155/2024/9347381. eCollection 2024.
7
Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review.黄酮类化合物与紫杉醇在癌症治疗中的协同作用:一项系统评价
Cancer Cell Int. 2023 Sep 24;23(1):211. doi: 10.1186/s12935-023-03052-z.
8
Cytotoxicity of curcumin against CD44 prostate cancer cells: Roles of miR-383 and miR-708.姜黄素对CD44前列腺癌细胞的细胞毒性:miR-383和miR-708的作用
Avicenna J Phytomed. 2023 Jul-Aug;13(4):429-441. doi: 10.22038/AJP.2023.21913.
9
Recent Advances in Curcumin-Based Combination Nanomedicines for Cancer Therapy.基于姜黄素的联合纳米药物用于癌症治疗的最新进展
J Funct Biomater. 2023 Aug 2;14(8):408. doi: 10.3390/jfb14080408.